Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Toward a New Drug for Multiple Sclerosis

September 22, 2014 – 12:00 am | Edit Post

On the occasion of positive new data for RPC1063, Professor Hugh Rosen shares his perspective on the drug candidate, which was initially discovered, synthesized and developed at TSRI.

New Genomic Equipment at TSRI Enables Scientists to Analyze Single Cells

September 22, 2014 – 12:00 am | Edit Post

“It has added power to many of the technologies we already have on campus,” says Professor Luc Teyton.

Mood switch found by UCSD scientists

September 19, 2014 – 6:37 pm | Edit Post

UCSD scientists found a twist in how bad news affects the brain, and depression therapy may benefit.

SGB Is Preparing for Commercial Roll Out of Jatropha

September 19, 2014 – 3:17 pm | Edit Post

SGB Inc., a local agricultural biotech company, has closed an $11 million Series C financing round to help drive the commercial roll out of its hybrid crops — a low-cost and sustainable plant-based option for fuel, energy-producing biomass and protein in animal feed.

Lpath raises $12.5 million

September 19, 2014 – 2:44 pm | Edit Post

Drug developer Lpath is selling $12.5 million of stock in a direct offering.

Pedal the Cause San Diego gears up for its second annual ride

September 19, 2014 – 11:07 am | Edit Post

Team Sanford-Burnham is gearing up for the big Pedal the Cause San Diego ride this Saturday and Sunday (Sept. 20 & 21). Pedal the Cause San Diego, the only multiday cycling fundraiser to support cancer research in San Diego, provides critical funding to the community’s three NCI-designated cancer centers.

A Better Way to Track Emerging Cell Therapies Using MRIs

September 19, 2014 – 10:43 am | Edit Post

Researchers at the University of California, San Diego School of Medicine, University of Pittsburgh and elsewhere describe the first human tests of using a perfluorocarbon (PFC) tracer in combination with non-invasive magnetic resonance imaging (MRI) to track therapeutic immune cells injected into patients with colorectal cancer.

BIO Announces Breakout Program Speakers for Pacific Rim Summit on Industrial Biotechnology

September 19, 2014 – 10:30 am | Edit Post

WASHINGTON–(BUSINESS WIRE)–The breakout session program for BIO’s ninth annual Pacific Rim Summit on Industrial Biotechnology and Bioenergy, to be held in San Diego in December 2014, will focus on technology commercialization.

Forum Highlights Innovators Working in Global Public Interest

September 19, 2014 – 3:30 am | Edit Post
Forum Highlights Innovators Working in Global Public Interest

Turning a valuable technology invention into a successful product is a lot like solving what public transit experts call the “last mile problem.” No matter how good your network of buses and trains,…

[[Click headline to continue reading.]]

Forum Highlights Innovators Working in Global Public Interest

September 19, 2014 – 3:30 am | Edit Post

Turning a valuable technology invention into a successful product is a lot like solving what public transit experts call the “last mile problem.” No matter how good your network of buses and trains,…
[[Click headline to continue reading.]]